Our services encompass the entire drug development cycle, from lead candidate selection to managing Chemistry, Manufacturing, and Controls (CMC) challenges, including formulation development, E&L, dissolution, stability, and regulatory submission filing. This comprises INDs, BLA, NDAs, NDSs, Pre-Submission Briefing documents, as well as post-market activities.
Our services span the development continuum from preclinical through post-approval and are customized to address specific development challenges of small molecules and biologics, vaccines, medical devices, and combination products.
Formulation Studies
Our pharmaceutical Development services include formulation development for a wide range of molecules, including controlled substances, small chemical, and large protein molecules…
Freeze Dry / Lyophilization
Synergy Bioscience has extensive expertise and state of the art equipment to develop lyophilized / Freeze Dry preparations with expanded capabilities that will meet your product’s…
Antibody Drug Conjugates
We offer dedicated Antibody Drug Conjugate (ADC) development support and pilot-scale manufacturing for clinical studies. ADC integrates antibody engineering, linker–payload chemistry, and bioconjugation to develop targeted therapeutic candidates.
Antibody Oligonucleotide Conjugates
We provide end‑to‑end development and pilot manufacturing for Antibody‑Oligonucleotide Conjugates (AOCs), combining antibody engineering, linker design, oligonucleotide chemistry and bioconjugation to produce small batches suitable for toxicology and early clinical studies.
Stem Cell Research
At Synergy Bioscience, we are committed to advancing the frontiers of medicine through our leading-edge stem cell research and development. With a foundation of highly qualified scientists…
Generics Development
Generic drugs play a pivotal role in the pharmaceutical industry, making up more than 80% of all prescriptions. They are equivalent to approved brand-name drugs, but cost around 85% less…